Evaluation of lymphangiogenic markers in Sézary syndrome

References

• Cueni LN, Detmar M. The lymphatic system in health and disease. Lymphat Res Biol 2008;6:109–122.
   PubMedGoogle Scholar
• Kanter MA. The lymphatic system: an historical perspective. Plast Reconstr Surg 1987;79:131–139.
   PubMed Web of Science ®Google Scholar
• Lord RS. The white veins: conceptual difficulties in the history of the lymphatics. Med Hist 1968;12:174–184.
   PubMedGoogle Scholar
• Flourens P, editor. A history of the discovery of the circulation of the blood. Cincinnati: Rickley, Mallory & Company; 1859.
   Google Scholar
• Achen MG, Jeltsch M, Kukk E, et al Vascular endothelial growth factor d (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (FLK1) and VEGF receptor 3 (FLT4). Proc Natl Acad Sci USA 1998;95:548–553.
   PubMed Web of Science ®Google Scholar
• Banerji S, Ni J, Wang SX, et al LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789–801.
   PubMed Web of Science ®Google Scholar
• Breiteneder-Geleff S, Matsui K, Soleiman A, et al Podoplanin, novel 43-kD membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997;151:1141–1152.
   PubMed Web of Science ®Google Scholar
• Joukov V, Pajusola K, Kaipainen A, et al A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290–298.
   PubMed Web of Science ®Google Scholar
• Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol 2005;21:457–483.
   PubMed Web of Science ®Google Scholar
• Kerjaschki D, Huttary N, Raab I, et al Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006;12:230–234.
   PubMedGoogle Scholar
• Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu Z, Cao Y. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 2005;106:4184–4190.
   PubMed Web of Science ®Google Scholar
• Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J Cell Mol Med 2009;13:1405–1416.
   PubMed Web of Science ®Google Scholar
• Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009;21:154–165.
   PubMed Web of Science ®Google Scholar
• Mandriota SJ, Jussila L, Jeltsch M, et al Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672–682.
   PubMed Web of Science ®Google Scholar
• Skobe M, Hawighorst T, Jackson DG, et al Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192–198.
   PubMed Web of Science ®Google Scholar
• Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005;5:735–743.
   Google Scholar
• Wroel T, Mazur G, Dziegiel P, et al Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes. Folia Histochem Cytobiol 2006;44:43–47.
   PubMed Web of Science ®Google Scholar
• Goydos JS, Gorski DH. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Cancer Res 2003;9:5962–5967.
   PubMed Web of Science ®Google Scholar
• Massi D, Puig S, Franchi A, et al Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 2006;59:166–173.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Opeskin K, Baldwin ME, et al Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 2004;10:5137–5144.
   PubMed Web of Science ®Google Scholar
• Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 2006;19:1317–1323.
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe ES, Burg G, et al WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3785.
   PubMed Web of Science ®Google Scholar
• Kamarashev J, Burg G, Kempf W, Hess Schmid M, Dummer R. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol 1998;25:407–412.
   PubMed Web of Science ®Google Scholar
• Mao X, Lillington D, Scarisbrick JJ, et al Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 2002;147:464–475.
   PubMed Web of Science ®Google Scholar
• Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol 2004;18:397–415.
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, et al Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–1722.
   PubMed Web of Science ®Google Scholar
• Vidulich KA, Talpur R, Bassett RL, Duvic M. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Int J Dermatol 2009;48:243–252.
   PubMed Web of Science ®Google Scholar
• Vonderheid EC, Pena J, Nowell P. Sezary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging. Leuk Lymphoma 2006;47:1841–1856.
   PubMed Web of Science ®Google Scholar
• Urosevic M, Kurrer MO, Kamarashev J, et al Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001;159:817–824.
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8.
   PubMed Web of Science ®Google Scholar
• Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005;7:121–127.
   PubMed Web of Science ®Google Scholar
• Debelenko LV, Perez-Atayde AR, Mulliken JB, Liang MG, Archibald TH, Kozakewich HP. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 2005;18:1454–1460.
   PubMed Web of Science ®Google Scholar
• Hong YK, Shin JW, Detmar M. Development of the lymphatic vascular system: a mystery unravels. Dev Dyn 2004;231:462–473.
   PubMed Web of Science ®Google Scholar
• Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001;22:317–321.
   PubMed Web of Science ®Google Scholar
• Kadowaki I, Ichinohasama R, Harigae H, et al Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol 2005;130:869–877.
   PubMed Web of Science ®Google Scholar
• Scavelli C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004;18:1054–1058.
   PubMed Web of Science ®Google Scholar
• Wrobel T, Dziegiel P, Mazur G, Zabel M, Kuliczkowski K, Szuba A. LYVE-1 expression on high endothelial venules (HEVS) of lymph nodes. Lymphology 2005;38:107–110.
   PubMed Web of Science ®Google Scholar
• Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann NY Acad Sci 2008;1131:1–12.
   PubMed Web of Science ®Google Scholar
• Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005;166:913–921.
   PubMed Web of Science ®Google Scholar
• Sonne SB, Herlihy AS, Hoei-Hansen CE, et al Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch 2006;449:200–206.
   PubMed Web of Science ®Google Scholar
• Aoki Y, Tosato G. Lymphatic regeneration: new insights from VEGFR-3 blockade. J Natl Cancer Inst 2005;97:2–3.
   PubMed Web of Science ®Google Scholar
• Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med 2006;12:127–136.
   PubMed Web of Science ®Google Scholar
• Man XY, Yang XH, Cai SQ, Bu ZY, Zheng M. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. Journal Cell Mol Med 2008;12:649–660.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Chen L, Saint-Geniez M, et al Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 2006;103:11405–11410.
   PubMed Web of Science ®Google Scholar
• Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406–2412.
   PubMed Web of Science ®Google Scholar
• Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF, Schlingemann RO. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 2002;43:849–857.
   PubMed Web of Science ®Google Scholar
• Longatto Filho A, Martins A, Costa SM, Schmitt FC. VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels. Pathol Res Pract 2005;201:93–99.
   PubMed Web of Science ®Google Scholar
• Jorgensen JM, Sorensen FB, Bendix K, et al Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors FLT-1, KDR, and FLT-4 in different subtypes of non-Hodgkin lymphomas. Leuk Lymphoma 2009;50:1647–1660.
   PubMed Web of Science ®Google Scholar
• Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573–583.
   PubMed Web of Science ®Google Scholar
• Orpana A, Salven P. Angiogenic and lymphangiogenic molecules in hematological malignancies. Leuk Lymphoma 2002;43:219–224.
   PubMed Web of Science ®Google Scholar
• Norgall S, Papoutsi M, Rossler J, Schweigerer L, Wilting J, Weich HA. Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer 2007;7:105.
   PubMed Web of Science ®Google Scholar
• Pazgal I, Boycov O, Shpilberg O, Okon E, Bairey O. Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas. Leuk Lymphoma 2007;48:2213–2220.
   PubMed Web of Science ®Google Scholar
• Paydas S, Ergin M, Seydaoglu G, Erdogan S, Yavuz S. Prognostic [corrected] significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature. Leuk Res 2009;33:1627–1635.
   PubMed Web of Science ®Google Scholar
• Paydas S, Seydaoglu G, Ergin M, Erdogan S, Yavuz S. The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas. Leuk Lymphoma 2009;50:366–373.
   PubMed Web of Science ®Google Scholar
• Mazur G, Wozniak Z, Wrobel T, Maj J, Kuliczkowski K. Increased angiogenesis in cutaneous T-cell lymphomas. Pathol Oncol Res 2004;10:34–36.
   PubMed Web of Science ®Google Scholar
• Schaerer L, Schmid MH, Mueller B, Dummer RG, Burg G, Kempf W. Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol 2000;22:140–143.
   PubMed Web of Science ®Google Scholar